Product Code: ETC13281110 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Extracorporeal Membrane Oxygenation Market was valued at USD 1.3 Billion in 2024 and is expected to reach USD 2.4 Billion by 2031, growing at a compound annual growth rate of 7.00% during the forecast period (2025-2031).
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is experiencing significant growth driven by the rising prevalence of respiratory and cardiac diseases, advancements in technology, and increasing awareness among healthcare professionals. ECMO is a life-saving technique that provides temporary support to patients with severe respiratory or cardiac failure. The market is characterized by the growing adoption of ECMO in both adult and pediatric patients, expanding applications beyond traditional indications, and the development of portable and miniaturized ECMO systems. Key players in the market are investing in research and development to enhance the efficacy and safety of ECMO devices, contributing to the market`s expansion. Geographically, North America holds a substantial market share due to the presence of leading healthcare facilities and high healthcare expenditure, while the Asia-Pacific region is expected to witness rapid growth due to improving healthcare infrastructure and increasing patient awareness.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is witnessing significant growth due to the rising prevalence of respiratory and cardiac diseases, advancements in ECMO technology, and increasing awareness about the benefits of ECMO therapy. Key trends in the market include the development of portable and miniaturized ECMO systems, growing adoption of ECMO in pediatric patients, and the integration of artificial intelligence and digital health technologies for improved patient monitoring and outcomes. Opportunities in the market lie in expanding applications of ECMO beyond traditional cardiac and respiratory support, increasing investments in research and development for innovative ECMO solutions, and the rising demand for ECMO in emerging markets. Overall, the ECMO market is poised for continued expansion driven by technological advancements and a growing patient population in need of advanced life support therapies.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market faces several challenges, including the high cost of ECMO equipment and procedures, which can limit accessibility for patients and healthcare facilities. Additionally, there is a shortage of skilled healthcare professionals trained in ECMO management, leading to potential gaps in patient care quality. Regulatory hurdles and varying reimbursement policies across different regions also pose challenges for market growth and adoption. Furthermore, the complexity of ECMO technology and the associated risks of complications such as bleeding and infection require continuous training and education for healthcare providers to ensure safe and effective use. Overall, addressing these challenges will be crucial for the sustained growth and advancements in the Global ECMO Market.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is primarily driven by the rising incidence of respiratory and cardiac diseases, leading to an increased demand for ECMO therapy as a life-saving intervention. Technological advancements in ECMO systems, such as improved pump designs and biocompatible materials, are also fueling market growth by enhancing the efficiency and safety of ECMO procedures. Additionally, the growing awareness among healthcare providers about the benefits of early ECMO intervention in critically ill patients and the expanding applications of ECMO in pediatric and neonatal care settings are further propelling market expansion. Moreover, the increasing investments in healthcare infrastructure and the rising healthcare expenditure in emerging economies are expected to drive the market for ECMO systems in the coming years.
Government policies related to the Global Extracorporeal Membrane Oxygenation (ECMO) Market vary by country, with regulations governing the use and reimbursement of ECMO therapy. In the United States, the Centers for Medicare and Medicaid Services (CMS) provides reimbursement for ECMO treatment under certain conditions, while the Food and Drug Administration (FDA) oversees the approval and regulation of ECMO devices. In Europe, the European Medicines Agency (EMA) regulates the approval and monitoring of ECMO devices for safety and efficacy. Additionally, some countries have specific guidelines for the allocation and use of ECMO resources in times of healthcare crises, such as during the COVID-19 pandemic. Overall, government policies aim to ensure the safe and effective use of ECMO therapy while also managing costs and access to this life-saving treatment.
The Global Extracorporeal Membrane Oxygenation (ECMO) Market is expected to witness significant growth in the coming years due to the increasing prevalence of respiratory and cardiac diseases, advancements in technology, and rising awareness about ECMO therapy. The market is projected to expand further as hospitals and healthcare facilities increasingly adopt ECMO for patients with severe respiratory or cardiac failure. Additionally, the growing geriatric population, coupled with the rising number of patients suffering from COVID-19 complications, is expected to drive the demand for ECMO devices and services. With ongoing research and development efforts aimed at improving ECMO technology and outcomes, the market is poised for substantial growth and innovation in the near future.
The Global Extracorporeal Membrane Oxygenation (ECMO) market shows varied regional dynamics. In Asia, the market is driven by the increasing prevalence of respiratory diseases and the rising adoption of advanced medical technologies. North America dominates the market due to high healthcare spending, technological advancements, and well-established healthcare infrastructure. Europe also holds a significant market share, propelled by the growing geriatric population and increasing cases of cardiac and respiratory disorders. The Middle East and Africa region is witnessing steady growth in the ECMO market, supported by improving healthcare infrastructure and rising awareness about ECMO therapy. Latin America is expected to show considerable growth potential in the coming years, driven by increasing investments in healthcare and growing awareness about advanced medical treatments like ECMO.
Global Extracorporeal Membrane Oxygenation Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Extracorporeal Membrane Oxygenation Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 & 2031F |
3.3 Global Extracorporeal Membrane Oxygenation Market - Industry Life Cycle |
3.4 Global Extracorporeal Membrane Oxygenation Market - Porter's Five Forces |
3.5 Global Extracorporeal Membrane Oxygenation Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Extracorporeal Membrane Oxygenation Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.7 Global Extracorporeal Membrane Oxygenation Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Global Extracorporeal Membrane Oxygenation Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Extracorporeal Membrane Oxygenation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Extracorporeal Membrane Oxygenation Market Trends |
6 Global Extracorporeal Membrane Oxygenation Market, 2021 - 2031 |
6.1 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Pumps, 2021 - 2031 |
6.1.3 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Oxygenators, 2021 - 2031 |
6.1.4 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Controllers, 2021 - 2031 |
6.1.5 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Cannula, 2021 - 2031 |
6.1.6 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Accessories, 2021 - 2031 |
6.2 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Neonates, 2021 - 2031 |
6.2.3 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.2.4 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.3.4 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.5 Global Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
7.1 North America Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
7.2 North America Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 North America Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 North America Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
8.1 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
8.4 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
8.5 Latin America (LATAM) Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
9.1 Asia Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
9.4 Asia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
9.5 Asia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
10.1 Africa Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
10.4 Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
10.5 Africa Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
11.1 Europe Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
11.4 Europe Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
11.5 Europe Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Extracorporeal Membrane Oxygenation Market, Overview & Analysis |
12.1 Middle East Extracorporeal Membrane Oxygenation Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Extracorporeal Membrane Oxygenation Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Component, 2021 - 2031 |
12.4 Middle East Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By Age Group, 2021 - 2031 |
12.5 Middle East Extracorporeal Membrane Oxygenation Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Extracorporeal Membrane Oxygenation Market Key Performance Indicators |
14 Global Extracorporeal Membrane Oxygenation Market - Export/Import By Countries Assessment |
15 Global Extracorporeal Membrane Oxygenation Market - Opportunity Assessment |
15.1 Global Extracorporeal Membrane Oxygenation Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Extracorporeal Membrane Oxygenation Market Opportunity Assessment, By Component, 2021 & 2031F |
15.3 Global Extracorporeal Membrane Oxygenation Market Opportunity Assessment, By Age Group, 2021 & 2031F |
15.4 Global Extracorporeal Membrane Oxygenation Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Extracorporeal Membrane Oxygenation Market - Competitive Landscape |
16.1 Global Extracorporeal Membrane Oxygenation Market Revenue Share, By Companies, 2024 |
16.2 Global Extracorporeal Membrane Oxygenation Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |